bioshares reported in it's newsletter today that acrux is well funded 25 million cash on hand.a steady stream of income can be expected now from milestone and royalty payments from sale of evamist(est $500,000 pa and growing very well)and from other future partners outside the usa,animal health products and from a male testosterone deal(bioshares estimated deal could be worth between $150 and 300 million us dollars to acrux)based on the above they stated that acrux is offering exceptional value to investors.
bioshares reported in it's newsletter today that acrux is well...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
-0.002(4.08%) |
Mkt cap ! $13.66M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.6¢ | $15.47K | 324.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 154451 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 120000 | 1 |
View Market Depth
| Last trade - 15.17pm 11/11/2024 (20 minute delay) ? |
| ACR (ASX) Chart |